Portal de Periódicos da CAPES

Hepatic Carcinoma Simulating Hyperparathyroidism

1963; Wiley; Volume: 173; Issue: 5 Linguagem: Inglês

10.1111/j.0954-6820.1963.tb17438.x

0001-6101

Sven‐Märten Samuelsson, Ivar Werner,

Childhood Cancer Survivors' Quality of Life

Acta Medica ScandinavicaVolume 173, Issue 5 p. 539-547 Hepatic Carcinoma Simulating Hyperparathyroidism Sven-Marten Samuelsson, Sven-Marten Samuelsson Department of Medicine (Head: E. Ask-Upmark, M.D.), University Hospital, Upsala, SwedenSearch for more papers by this authorIvar Werner, Ivar Werner Department of Medicine (Head: E. Ask-Upmark, M.D.), University Hospital, Upsala, SwedenSearch for more papers by this author Sven-Marten Samuelsson, Sven-Marten Samuelsson Department of Medicine (Head: E. Ask-Upmark, M.D.), University Hospital, Upsala, SwedenSearch for more papers by this authorIvar Werner, Ivar Werner Department of Medicine (Head: E. Ask-Upmark, M.D.), University Hospital, Upsala, SwedenSearch for more papers by this author First published: January/December 1963 https://doi.org/10.1111/j.0954-6820.1963.tb17438.xCitations: 23AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Abouav, J., Berkowitz, S. B. & Kolb, F. O.: Reversible hypercalcemia in masculinizing hypernephroid tumor of the ovary. New Engl. J. Med. 260: 1057, 1959. 10.1056/NEJM195905212602102 CASPubMedWeb of Science®Google Scholar 2 Adair, F. E., Mellors, R. C., Farrow, J. H., Woodard, H. Q., Escher, G. C. & Urban, J. A.: The use of estrogens and androgens in advanced mammary cancer. Clinical and laboratory study of one hundred and five female patients. J. A. M. A. 140: 1193, 1949. 10.1001/jama.1949.02900500001001 PubMedWeb of Science®Google Scholar 3 Albright, F. & Reifenstein, E. C., Jr.: The parathyroid glands and metabolic bone disease — selected studies. Williams & Wilkins, Baltimore 1948, p. 93. Google Scholar 4 Allott, E. N. & Skelton, M. O.: Increased adrenocortical activity associated with malignant disease. Lancet 2: 278, 1960. 10.1016/S0140-6736(60)91374-X CASPubMedWeb of Science®Google Scholar 5 August, J. T. & Hiatt, H. H.: Severe hypoglycemia secondary to a nonpancreatic fibrosarcoma with insulin activity. New Engl. J. Med. 258: 17, 1958. 10.1056/NEJM195801022580104 CASPubMedWeb of Science®Google Scholar 6 Baker, W. H.: Abnormalities in calcium metabolism in malignancy. Effects of hormone therapy. Amer. J. Med. 21: 714, 1956. 10.1016/0002-9343(56)90087-0 CASPubMedGoogle Scholar 7 Bodansky, O.: Blood biochemical alterations in neoplastic disease. Med. Clin. N. Amer. 40: 611, 1956. 10.1016/S0025-7125(16)34555-2 CASPubMedWeb of Science®Google Scholar 8 Bornstein, P., Nolan, J. P. & Bernanke, D.: Adrenocortical hyperfunction in association with anaplastic carcinoma of the respiratory tract. New Engl. J. Med. 244: 363, 1961. 10.1056/NEJM196102232640801 Web of Science®Google Scholar 9 Brickner, P. W., Lyons, M. & Landau, S. J.: Cushing's syndrome associated with non-endocrine neoplasms. Amer. J. Med. 31: 632, 1961. 10.1016/0002-9343(61)90145-0 CASPubMedWeb of Science®Google Scholar 10 Burr, J. M., Farrell, J. J. & Hills, A. G.: Sarcoidosis and hyperparathyroidism with hypercalcemia. Special usefulness of the cortison test. New Engl. J. Med. 261: 1271, 1959. 10.1056/NEJM195912172612504 CASPubMedWeb of Science®Google Scholar 11 Case records Mass. Gen. Hosp. Case 27461. New Engl. J. Med. 225: 789, 1941. 10.1056/NEJM194111132252007 Google Scholar 12 Case records Mass. Gen. Hosp. Case 39061. New Engl. J. Med. 248: 248, 1953. 10.1056/NEJM195302052480607 Google Scholar 13 Case records Mass. Gen. Hosp. Case 43161. New Engl. J. Med. 256: 750, 1957. 10.1056/NEJM195704182561608 Google Scholar 14 Case records Mass. Gen. Hosp. Case 9–1961. New Engl. J. Med. 264: 242, 1961. 10.1056/NEJM196102022640511 Google Scholar 15 Connor, T. B., Thomas, W. C., Jr. & Howard, J. E.: The etiology of hypercalcemia associated with lung carcinoma. J. Clin. Invest. 35: 697, 1956. Web of Science®Google Scholar 16 Cope, O., Barnes, B. A., Castleman, B., Mueller, G. C. E. & Roth, S. I.: Vicissitudes of parathyroid surgery: trials of diagnosis and management in 51 patients with a variety of disorders. Ann. Surg. 154: 491, 1961. 10.1097/00000658-196110000-00002 CASPubMedWeb of Science®Google Scholar 17 David, N. J., Verner, J. V. & Engel, F. L.: The diagnostic spectrum of hypercalcemia. Amer. J. Med. 33: 88, 1962. 10.1016/0002-9343(62)90280-2 CASPubMedGoogle Scholar 18 Ellman, P. & Parfitt, A. M.: The resemblance between sarcoidosis with hypercalcemia and hyperparathyroidism. Brit. med. J. 5192: 108, 1960. 10.1136/bmj.2.5192.108 CASGoogle Scholar 19 Escovitz, W. E. & Reingold, I. M.: Functioning malignant bronchial carcinoid with Cushing's syndrome and recurrent sinus arrest. Ann. intern. Med. 54: 1248, 1961. 10.7326/0003-4819-54-6-1248 CASPubMedWeb of Science®Google Scholar 20 Gold, G. L. & Shnider, B. I.: Some unusual syndromes associated with neoplastic disease. Ann. intern. Med. 51: 890, 1959. 10.7326/0003-4819-51-5-890 CASPubMedWeb of Science®Google Scholar 21 Gutman, A. B., Tyson, T. L. & Gutman, E. B.: Scrum calcium, inorganic phosphorus and phosphatase activity in hyperparathyroidism, Paget's disease, multiple myeloma and neoplastic disease of the bones. Arch. intern. Med. 57: 379, 1936. 10.1001/archinte.1936.00170060141006 CASWeb of Science®Google Scholar 22 Hed, R.: Some disturbances in calcium metabolism from the aspect of internal medicine. Opusc. med. (Stockh.) 7: 87, 1962. Google Scholar 23 Henneman, P. H., Carroll, E. L. & Dempsey, E. F.: The mechanism responsible for hypercalcuria in sarcoid. J. Clin. Invest. 33: 941, 1954. Google Scholar 24 Henneman, P. H., Dempsey, E. F., Carroll, E. L. & Albright, F.: The cause of hypercalcuria in sarcoid and its treatment with cortisone and sodium phytate. J. Clin. Invest. 35: 1229, 1956. 10.1172/JCI103378 CASPubMedWeb of Science®Google Scholar 25 Knowles, J. H. & Smith, L. H., Jr.: Extrapulmonary manifestations of bronchogenic carcinoma. New Engl. J. Med. 262: 505, 1960. 10.1056/NEJM196003102621006 CASPubMedWeb of Science®Google Scholar 26 Laird Myers, W. P.: Clinical aspects and management of hypercalcemia. Med. Clin. N. Amer. 40: 871, 1956. 10.1016/S0025-7125(16)34571-0 CASPubMedWeb of Science®Google Scholar 27 Laird Myers, W. P.: Hypercalcemia in neoplastic disease. Cancer 9: 1135, 1956. 10.1002/1097-0142(195611/12)9:6 3.0.CO;2-6 CASPubMedWeb of Science®Google Scholar 28 Laird Myers, W. P., West, C. D., Pearson, O. H. & Karnofsky, D. A.: Androgcninduced exacerbation of breast cancer measured by calcium excretion. Conversion of androgen to estrogen as a possible underlying mechanism. J. A. M. A. 161: 127, 1956. 10.1001/jama.1956.02970020007002 Google Scholar 29 Laszlo, D., Schulman, C. A., Bellin, S., Gottesman, F. D. & Schilling, A.: Mineral and protein metabolism in osteolytic metastases. J. A. M. A. 148: 1027, 1952. 10.1001/jama.1952.62930120003012 CASPubMedWeb of Science®Google Scholar 30 Lewis, J. M., Searle, N. B. & Jordan, G. L.: Cushing's syndrome and bronchogenic carcinoma. Ann. intern. Med. 52: 1138, 1960. 10.7326/0003-4819-52-5-1138 CASPubMedWeb of Science®Google Scholar 31 Lucas, P. F.: Acute hypercalcemia from carcinomatosis without bone metastasis. Brit. Med. J. 1: 1330, 1960. 10.1136/bmj.1.5182.1330 CASPubMedWeb of Science®Google Scholar 32 Marks, L. J., Anderson, A. E. & Liberman, H.: Carcinoma of the lung associated with marked adrenocortical hyperplasia and adrenal hyperresponsiveness to ACTH in the absence of Cushing's syndrome. Ann. intern. Med. 54: 1243, 1961. 10.7326/0003-4819-54-6-1243 CASPubMedWeb of Science®Google Scholar 33 McGeown, M. G. & Montgomery, D. A. D.: Multiple myelomatosis simulating hyperparathyroidism. Brit. Med. J. I: 86, 1956. 10.1136/bmj.1.4958.86 CASGoogle Scholar 34 Pearson, O. H., West, C. D., Hollander, V. P. & Treves, N.: Evaluation of endocrine therapy for advanced breast cancer. J. A. M. A. 154: 234, 1954. 10.1001/jama.1954.02940370046013 CASPubMedWeb of Science®Google Scholar 35 Plimpton, C. H. & Gellhorn, A.: Hypercalcemia in malignant disease without evidence of bone destruction. Amer. J. Med. 21: 750, 1956. 10.1016/0002-9343(56)90091-2 PubMedWeb of Science®Google Scholar 36 Reiss, E. & Alexander, F.: The tubular reabsorption of phosphate in the differential diagnosis of metabolic bone disease. J. Clin. Endocrin. 19: 1212, 1959. 10.1210/jcem-19-10-1212 CASPubMedWeb of Science®Google Scholar 37 Riggs, B. L., Jr. & Sprague, R. G.: Association of Cushing's syndrome and neoplastic disease. Arch. intern. Med. 108: 841, 1961. 10.1001/archinte.1961.03620120025005 PubMedWeb of Science®Google Scholar 38 Schatten, W. E., Ship, A. G., Pieper, W. J. & Bartter, F. C.: Syndrome resembling hyperparathyroidism associated with squamous cell carcinoma. Ann. Surg. 148: 890, 1958. 10.1097/00000658-195812000-00004 CASPubMedWeb of Science®Google Scholar 39 Scholz, D. A., Woolner, L. B. & Priestley, J. T.: Spontaneous hypoglycemia associated with fibrogenic tumor: report of two cases. Ann. intern. Med. 46: 796, 1957. 10.7326/0003-4819-46-4-796 CASPubMedWeb of Science®Google Scholar 40 Schwartz, W. B., Bennett, W., Curelop, S. & Bartter, F. C.: A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Amer. J. Med. 23: 529, 1957. 10.1016/0002-9343(57)90224-3 CASPubMedWeb of Science®Google Scholar 41 Silverstein, M. N., Wakim, K. G., Bahn, R. C. & Bayrd, E. P.: Additional preliminary observations on the hypoglycemic factor. Proc. Mayo Clin. 37: 95, 1962. CASPubMedWeb of Science®Google Scholar 42 Silvis, R. S. & Simon, D. S.: Marked hypoglycemia associated with nonpancreatic tumors. New Engl. J. Med. 254: 14, 1956. 10.1056/NEJM195601052540104 CASPubMedWeb of Science®Google Scholar 43 Snapper, I.: Influence of 2-hydroxystilbamidine on the course of multiple myeloma. J. Mt Sinai Hosp. 15: 156, 1948. CASGoogle Scholar 44 Solomon, R. B. & Channick, B. J.: Bocck's sarcoidosis simulating hyperparathyroidism. Ann. intern. Med. 53: 1232, 1960. 10.7326/0003-4819-53-6-1232 Google Scholar 45 Stewart, G. S. & Bowen, H. F.: Urinary phosphate excretion factor of parathyroid gland extracts: hormone or artefact Endocrinology 51: 80, 1952. 10.1210/endo-51-2-80 CASPubMedWeb of Science®Google Scholar 46 Stone, G. E., Waterhouse, C. & Terry, R.: Hypercalcemia of malignant disease: case report and a proposed mechanism of etiology. Ann. intern. Med. 54: 977, 1961. 10.7326/0003-4819-54-5-977 Web of Science®Google Scholar 47 Studer, H. & Quinodoz, J. M.: Hypercalcémic et cancer du sein. J. Suisse Méd. 90: 126, 1960. CASPubMedGoogle Scholar 48 Swyer, A. J., Bercer, J. S., Gordon, H. M. & Laszlo, D.: Hypercalcemia in osteolytic metastatic cancer of the breast. Amer. J. Med. 8: 724, 1950. 10.1016/0002-9343(50)90096-9 CASPubMedWeb of Science®Google Scholar 49 Thomas, W. C., Jr., Connor, T. B. & Morgan, H. G.: Some observations on patients with hypercalcemia exemplifying problems in differential diagnosis, especially in hyperparathyroidism. J. Lab. Clin. Med. 52: 11, 1958. PubMedWeb of Science®Google Scholar 50 Thomas, W. C., Jr., Connor, T. B. & Morgan, H. G.: Diagnostic considerations in hypercalcemia with a discussion of the various means by which such a state may develop. New Engl. J. Med. 260: 591, 1959. 10.1056/NEJM195903192601205 PubMedWeb of Science®Google Scholar 51 Thorne, M. G.: Cushing's syndrome associated with bronchial carcinoma. Guy's Hosp. Rep. 101: 251, 1952. CASPubMedGoogle Scholar 52 Wilson, J. R., Merrick, H. & Woodward, E. R.: Hypercalcemia simulating hyperparathyroidism induced by XV-2 carcinoma of rabbit. Ann. Surg. 154: 485, 1961. 10.1097/00000658-196109000-00017 CASPubMedWeb of Science®Google Scholar 53 Woodard, H. Q.: Changes in blood chemistry associated with carcinoma metastatic to bone. Cancer 6: 1219, 1953. 10.1002/1097-0142(195311)6:6 3.0.CO;2-B CASPubMedWeb of Science®Google Scholar 54 Woodard, H. Q., Escher, G. C. & Farrow, J.: Changes in the blood chemistry of patients with disseminated carcinoma of the breast during endocrine therapy. Cancer 7: 744, 1954. 10.1002/1097-0142(195407)7:4 3.0.CO;2-0 CASPubMedWeb of Science®Google Scholar Citing Literature Volume173, Issue5January/December 1963Pages 539-547 ReferencesRelatedInformation